JHSM
Journal of Health Sciences and Medicine

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

ISSN: Active
eISSN: 2636-8579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
The leuko-glycemic index can predict multivessel disease in the elderly acute myocardial infarction population? a retrospective cohort study
Abstract
Aims: Cardiovascular diseases are still the leading cause of death, as the cause of approximately 30% of all deaths in the world and half of all deaths due to cardiovascular diseases also consist of individuals aged 70 and older. The leukoglycemic index (LGI) is a new parameter associated with mortality, complication, and prognosis in cardiovascular diseases. It can be applied easily at the bedside, has a low cost, and consists of a combination of leukocytes and glucose. In our study, we aimed to evaluate the predictive effect of leukoglycemic index on multivessel disease in elderly patients over 65 who were hospitalized with acute myocardial infarction.
Methods: In our retrospective cohort study, patients over 65 who were hospitalized with the diagnosis of acute myocardial infarction were included. LGI was calculated with the formula: blood glucose × white blood cell/1000. All datas about patients were collected from the electronic hospital information system, patient files and our hospital’s archive.
Results: The patients were divided into two groups: single-vessel disease and multivessel disease. The laboratory parameters of the patients were compared, and LGI (1532.5 (577.7-3770.3) vs 2077.9 (646.6-5301); p<0.001) were found to be significantly different between the two groups. According to unadjusted univariate log regression analysis, LGI was statistically significant in predicting multivessel disease (OR: 1.724, 95% CI: (1.222-2.432), p=0.002). After adjusting the model by adding clinically and statistically significant variables, LGI remained an independent predictor of multivessel disease (OR: 1.599, 95% CI (1.086-2.357), p=0.018). The discrimination ability of LGI was analyzed with ROC curve analysis. The LGI AUC value was 0.619 (95% Cl, 0.544-0.695, p=0.003).
Conclusion: Our study showed that high LGI is an independent predictor of multivessel coronary artery disease in elderly patients with acute myocardial infarction.

Keywords : Blood glucose, coronary artery disease, elderly, leukocyte, myocardial infarction

Download Article


1. İkitimur B. Yaşlılarda koroner arter hastalığına yaklaşım. TurkKardiyol Dern Ars. 2017;45(5):32-34.
2. Gad&oacute; K, Szabo A, Markovics D, Vir&aacute;g A. Most commoncardiovascular diseases of the elderly-a review article. DevelopHealth Sci. 2022;4(2):27-32.
3. Manfredi G, Mid&atilde;o L, Pa&uacute;l C, Cena C, Duarte M, CostaE. Prevalence of frailty status among the European elderlypopulation: Findings from the Survey of Health, Aging andRetirement in Europe. Geriatr Gerontol Int. 2019;19(8):723-729.
4. Sadeghi R, Roshdi Dizaji S, Vazirizadeh-Mahabadi M, SarveazadA, Forouzannia SA. Prognostic value of the leuko-glycemic indexin acute myocardial infarction; a systematic review and meta-analysis. Arch Acad Emerg Med. 2023;11(1):e25.
5. Qi LY, Liu HX, Cheng LC, et al. Prognostic value of the leuko-glycemic index in acute myocardial infarction patients with orwithout diabetes. Diabetes Metab Syndr Obes. 2022;1725-1736.
6. Kilic O, Buber I, Kahraman F. Predicting the severity of coronaryartery disease: can the leukocyte glucose index be used? J CollPhysicians Surg Pak. 2022; 32(12):1519-1523.
7. Quiroga W, Conci E, Zelaya F, Isa M, Pacheco G, Sala J.Estratificaci&oacute;n del riesgo en el infarto agudo de miocardio seg&uacute;nel &iacute;ndice leucogluc&eacute;mico.&iquest; El Killip-Kimball de laboratorio. RevFed Arg Cardiol. 2010;39(1):29-34.
8. Menon V, Lessard D, Yarzebski J, Furman MI, Gore JM, GoldbergRJ. Leukocytosis and adverse hospital outcomes after acutemyocardial infarction. Am J Cardiol. 2003;92(4):368-372.
9. Furman MI, Gore JM, Anderson FA, et al. Elevated leukocytecount and adverse hospital events in patients with acute coronarysyndromes: findings from the Global Registry of Acute CoronaryEvents (GRACE). Am Heart J. 2004;147(1):42-48.
10. Madjid M, Fatemi O. Components of the complete blood countas risk predictors for coronary heart disease: in-depth review andupdate. Tex Heart Inst J. 2013;40(1):17.
11. Weissberg PL, Bennett MR. Atherosclerosis--an inflammatorydisease. N Engl J Med. 1999;340(24):1928-1929.
12. Ates AH, Canpolat U, Yorgun H, et al. Total white blood cell countis associated with the presence, severity and extent of coronaryatherosclerosis detected by dual-source multislice computedtomographic coronary angiography. Cardiol J. 2011;18(4):371-377.
13. Kim JH, Lim S, Park KS, Jang HC, Choi SH. Total and differentialWBC counts are related with coronary artery atherosclerosis andincrease the risk for cardiovascular disease in Koreans. PLoS One.2017;12(7):e0180332.
14. Deckers JW, van Domburg RT, Akkerhuis M, Nauta ST. Relation ofadmission glucose levels, short-and long-term (20-year) mortalityafter acute myocardial infarction. Am J Cardiol. 2013;112(9):1306-1310.
15. Kewcharoen J, Ali M, Trongtorsak A, Mekraksakit P, VutthikraivitW, Kanjanauthai S. Admission hyperglycemia is associated withreperfusion failure in patients with ST-elevation myocardialinfarction undergoing primary percutaneous coronaryintervention: a systematic review and meta-analysis. Am JCardiovasc Dis. 2021;11(3):348-359.
16. Terlecki M, Bednarek A, Kawecka-Jaszcz K, Czarnecka D,Bryniarski L. Acute hyperglycaemia and inflammation in patientswith ST segment elevation myocardial infarction. KardiologiaPolska (Polish Heart J). 2013;71(3):260-267.
17. Alavi-Moghaddam M, Parsa-Mahjoob M, Ghodssi-GhassemabadiR, Bitazar B. Association of admission blood glucose level withmajor adverse cardiac events in acute coronary syndrome; acohort study. Arch Acad Emerg Med. 2019;7(1):e26.
18. Ishihara M, Kojima S, Sakamoto T, et al. Japanese Acute CoronarySyndrome Study (JACCS) Investigators: Comparison of bloodglucose values on admission for acute myocardial infarction inpatients with versus without diabetes mellitus. Am J Cardiol.2009;104(6):769-774.
19. Bergmark BA, Mathenge N, Merlini PA, Lawrence-WrightMB, Giugliano RP. Acute coronary syndromes. Lancet. 2022;399(10332):1347-1358.
20. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and strokestatistics&mdash;2014 update: a report from the American HeartAssociation. Circulation. 2014;129(3):e28-292.
21. Veerasamy M, Bagnall A, Neely D, Allen J, Sinclair H, Kunadian V.Endothelial dysfunction and coronary artery disease. Cardiol Rev.2015;23(3):119-129.
22. Zimbardo G, Cialdella P, Di Fusco P, et al. Acute coronarysyndromes and multivessel coronary artery disease. Eur Heart JSuppl. 2023;25(Supplement_C):C74-8.
23. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelineson cardiovascular disease prevention in clinical practice.Kardiologia Polska (Polish Heart J). 2016;74(9):821-936.
24. Saunderson CE, Brogan RA, Simms AD, Sutton G, Batin PD,Gale CP. Acute coronary syndrome management in olderadults: guidelines, temporal changes and challenges. Age Ageing.2014;43(4):450-455. doi:10.1093/ageing/afu034
25. Mehta RH, Rathore SS, Radford MJ, Wang Y, Wang Y, KrumholzHM. Acute myocardial infarction in the elderly: differences byage. J Am Coll Cardiol. 2001;38(3):736-741.
26. Derek Y, Hawkes C, Gould L, Hofman K. The global burden ofchronic diseases. JAMA. 2004;291(21):2616-2622.
27. Lye M, Donnellan C. Heart disease in the elderly. Heart.2000;84(5):560-566.
28. Lakatta EG. Age-associated cardiovascular changes in health:impact on cardiovascular disease in older persons. Heart Fail Rev.2002;7(1):29-49.
29. Kochar A, Chen AY, Sharma PP, et al. Long-term mortality ofolder patients with acute myocardial infarction treated in USclinical practice. J Am Heart Assoc. 2018;7(13):e007230.
30. Avezum A, Makdisse M, Spencer F, et al. Impact of age onmanagement and outcome of acute coronary syndrome:observations from the Global Registry of Acute Coronary Events(GRACE). Am Heart J. 2005;149(1):67-73.
31. Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel diseaseon reperfusion success and clinical outcomes in patientsundergoing primary percutaneous coronary intervention foracute myocardial infarction. Eur Heart J. 2007;28(14):1709-1716.
32. de Carvalho Cantarelli MJ, Castello Jr HJ, Gon&ccedil;alves R, et al.Independent predictors of multivessel coronary artery disease:results from Angiocardio Registry. Revista Brasileira de CardiologiaInvasiva (English Edition). 2015;23(4):266-270.
Article available in :
Volume 6, Issue 5, 2023
Page : 1119-1124
https://doi.org/10.32322/jhsm.1349575
Article Information
Received : 25 Ağu 2023
Accepted : 17 Eyl 2023
Published : 28 Eyl 2023
Corresponding Author :

Mevlüt Demir: Department of Cardiology, Faculty of Medicine, Kütahya Health Sciences University, Kütahya, Turkey

[email protected]
Citation : Demir M. The leuko-glycemic index can predict multivessel disease in the elderly acute myocardial infarction population? a retrospective cohort study. J Health Sci Med. 2023;6(5):1119-1124.

Read: 127
Cited: 3
Download : 173
_Footer